September 26, 2017 M&A, Partnerships Molecular Spectroscopy

Hamamatsu Photonics K.K. to acquire Energetiq Technology Inc. of Woburn, Massachusetts, U.S.A.

BRIDGEWATER, N.J., Sept. 26, 2017 /PRNewswire/ — Hamamatsu Photonics K.K. announces an agreement to acquire Energetiq Technology Inc. (EQ), a manufacturer of Laser Driven Light Sources (LDLS™) and Extreme Ultraviolet (EUV) light sources. The agreement, if consummated, will bring Energetiq into the consolidated group of companies that are owned by Photonics Management Corp. (PMC), of Bridgewater, NJ (USA). Hamamatsu Photonics... Read more

September 25, 2017 M&A, Partnerships Microscopy

ZEISS Invests €30 Million in Innovation Hub at KIT

ZEISS and KIT make plans for shared innovation building KIT carve-outs offer long-term prospects at site More modern growth environment for successful Karlsruhe-based company Nanoscribe GmbH ZEISS and KIT promote strategic partnership OBERKOCHEN/Germany, 2017-09-25. ZEISS plans to build a new shared innovation hub on the north campus of the Karlsruhe Institute of Technology (KIT). Construction... Read more

September 21, 2017 M&A, Partnerships Microscopy

Oxford Instruments collaborates with CASmF Science and Technology Limited in China for developing high performance SPM products

21 September 2017 Oxford Instruments NanoScience announces the long-term collaboration agreement signed with CASmF Science and Technology Limited (CASmF) in China, to jointly develop high precision Scanning Probe Microscope (SPM) products using TeslatronPT, the Cryofree® superconducting magnet system from Oxford Instruments. SPM products form images of surfaces using a physical probe that scans the specimen. The SPM probe when used... Read more

September 21, 2017 Clinical Research/Diagn. M&A, Partnerships

Hitachi High-Technologies Enters the Cancer Diagnostic Testing Service Business through Capital Participation in U.S. Company MagArray, Inc.

Tokyo, Japan, September 21, 2017—Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced today that it would enter the diagnostic testing service business by accepting a private placement of new shares by MagArray, Inc. (MagArray) of the U.S. to make it an equity-method affiliate. Hitachi High-Tech has made the field of biotechnology and healthcare its priority.... Read more

September 20, 2017 Atomic Spectroscopy Life Science Tools M&A, Partnerships

CDI Signs Agreement with Nanion to Enhance Mutual Offerings for Researchers

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Astrocytes iCell Cardiac Progenitor Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell DopaNeurons iCell Endothelial Cells iCell GABANeurons iCell GlutaNeurons iCell Hematopoietic Progenitor Cells iCell Hepatoblasts iCell Hepatocytes... Read more

September 20, 2017 Cell Analysis Tools M&A, Partnerships

Cellular Dynamics International Signs Agreement with Nanion Technologies to Enhance Mutual Offerings for Researchers

Madison, Wisconsin, September 20, 2017— Cellular Dynamics International (CDI), a FUJIFILM company , the leading developer and manufacturer of differentiated cells derived from human induced pluripotent stem cells (iPSCs), and Nanion Technologies GmbH (Nanion), a leading provider of instrumentation for ion channel drug discovery and screening, announced today that they have entered into a joint marketing agreement. The... Read more

September 20, 2017 M&A, Partnerships

BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens

FRANKLIN LAKES, N.J. and SIZIANO, Italy, Sept. 20, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution agreement for molecular tests to detect emerging sexually-transmitted pathogens. According to the World Health Organization, more than 1 million... Read more

September 19, 2017 Lab Top-10 M&A, Partnerships

Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer

Announcing the Single-Cell Printer for documented isolation of cells in clonal cell line development Sunnyvale, Calif. – September 19, 2017 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated microfluidics-based technology... Read more

September 13, 2017 Clinical Research/Diagn. M&A, Partnerships

Fabric Genomics and Genome Medical Partner to Help Patients and Clinicians Better Understand Genetic Results

September 13, 2017 06:00 AM Pacific Daylight Time OAKLAND, Calif. & SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing... Read more

September 13, 2017 Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V.

Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V. WALTHAM, Mass., Sept. 13, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the expiration of the subsequent offering period of its previously announced tender offer to purchase all of the outstanding ordinary shares... Read more